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ABSTRACT
The relationship between food consumption and health outcomes has become a priority research focus in Canada. This has
driven an emerging interest in functional foods, natural health products and nutrigenomics. Capitalizing on its abundant natural
resources, world class research expertise, renown facilities and collaborative research environment, Canadian researchers are
developing innovative approaches to reduce the incidence of diseases such as hypertension, diabetes type II and cardiovascular
disease. Canada boasts approximately 15 government research centres, 16 universities and colleges, 4 technology centres and 2
institutes actively carrying out research in the area of functional foods, natural health products and nutrigenomics. These include
three organizations, The Institute of Functional Foods and Nutraceuticals, The Richardson Centre for Functional Foods and
Nutraceuticals, and The Canadian Centre for Agri-food Research in Health and Medicine, that are solely dedicated to food and
health research. Many of the researchers at these organizations have benefited from investments from the Government of Canada
through both the Advanced Foods and Material Network and the Canada Research Chairs Program, that have made significant
investments in cutting edge functional food, natural health product and nutrigenomics research in Canada.
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INTRODUCTION
Consumers are becoming increasingly aware of the
connection between diet and health and are actively
seeking out nutritional-based strategies that have the potential to prevent disease and improve health and
well-being. Canada is home to many world-class functional foods and natural health products companies and
research and development activities, that capitalize on
this increased interest and Canada’s strengths in the food
and agriculture sectors. Canadian organizations are examining the mechanism and efficacy of functional foods,
natural health products and other bioactive compounds in
relation to the potential reduction and/or prevention of
diet related chronic disease such as diabetes, obesity and
cardiovascular disease. Recently, the influence of the
relationship between genetics and diet (nutrigenomics) on
the above relationships has also received increased attention.

WHAT ARE FUNCTIONAL FOODS?
There is currently no consensus on a standard definition for functional foods in Canada, however, the Bureau
of Nutritional Sciences, of the Food Directorate of Health
Canada, defines a functional food as a “food that is similar in appearance to, or may be a conventional food, that

is consumed as part of a usual diet and that is demonstrated to have physiological benefits or that reduces the
risk of chronic disease beyond basic nutritional functions.” Functional foods may be created through activities such as fortification with vitamins and minerals, addition of bioactive components, or bioactive component
enhancement through processing, plant breeding, or animal feed enhancement(1). Examples include yogurt with
probiotics; omega-3 eggs, milk and meat; fortified soy
beverages; among others.

WHAT ARE NATURAL HEALTH PRODUCTS?
In 1998 the Bureau of Nutritional Sciences, of the
Food Directorate of Health Canada recognized a
nutraceutical as “a product isolated or purified from foods
that is generally sold in medicinal forms not usually associated with food. A nutraceutical is demonstrated to have
a physiological benefit or provide protection against
chronic disease.” The term nutraceutical has since been
replaced by the Directorate by the broader term, Natural
Health Products. Natural health products are defined as
“vitamins and minerals, herbal remedies, homeopathic
medicines, traditional medicines, probiotics, and other
products like amino acids and essential fatty acids” that
are “…safe to use as over-the-counter products and not
need a prescription to be sold” .
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WHAT IS NUTRIGENOMICS?
Nutrigenomics is an emerging discipline of science
that assesses how nutrients affect genes (e.g., gene expression) and how genes affect nutrient metabolism (e.g.,
genetic variation affecting caffeine metabolism), impacting specific health outcomes. The science of nutrigenomics is underpinned by bioinformatics, genomics, molecular biology and nutrition(2), which when combined are
used to understand differences and similarities in genetic
expression across a population in relation to diet. Nutrigenomics research assesses the relationship between
genes and nutrient absorption, metabolism, taste perception and satiation(3).

CANADIAN BENEFITS
Canada’s research and development expertise in
functional foods, natural health products and nutrigeneomics is world renown for both quality and innovation.
The sector takes advantages of Canada’s competitive
strength including its abundant natural resources; stringent regulatory system; world class research facilities;
and collaborative environment involving all levels of
government, academia, and private industry. In 2007 a
functional foods and natural health products survey indicated that there were 689 firms, employing 100,353 individuals, in the field of functional foods and natural health
products with a total revenue of $21.5 billion(4). Additionally, there are approximately 15 government research
centres, 16 universities and colleges, 4 technology centres
and 2 institutes actively carrying out research in the area
of functional foods and natural health products and nutrigenomics.
Canada has three major organizations solely dedicated to the research and development of functional foods
and natural health products: The Richardson Centre for
Functional Foods and Nutraceuticals, The Institute of
Functional Foods and Nutraceuticals, and The Canadian
Centre for Agri-food Research in Health and Medicine.
Additionally, the Advanced Foods and Materials Network
(AFMNet) has invested in cutting edge research in functional foods, natural health products and nutrigenomics.

RICHARDSON CENTRE FOR FUNCTIONAL
FOODS AND NUTRACEUTICALS
The Richardson Centre for Functional Foods and
Nutraceuticals is located at the University of Manitoba, in
Winnipeg, Manitoba. It is dedicated the research and development of functional foods and natural health products,
and economic viability of the industry with a strong focus
on the crops of the Canadian Prairies (flax, canola, pulses,
and buckwheat). The facility boasts world-renown analytical labs, animal model research facilities, a clinical
research unit, pilot plants, and formulation development
and natural health product manufacturing capabilities.
The Richardson Centre boasts three Canada Research
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Chairs: Dr. Peter Eck, Canada Research Chair
Nutrigenomics; Dr. Peter Jones, Canada Research Chair
in Nutritional and Functional Foods; and Dr. Trust Beta,
Canada Research Chair, Food Processing for Grain-Based
Functional Foods. The Canada Research Chairs program
is run by the Government of Canada and invests $300
million dollars per year to attract and retain some of the
world's most accomplished and promising minds.
Canada Research Chairs demonstrate research excellence
in engineering and the natural sciences, health sciences,
humanities, and social sciences. The program is designed
to strengthen Canada's international competitiveness,
train the next generation of highly qualified personnel and
produce high impact research.
Dr. Peter Jones, Director of the Richardson Centre,
focuses on cholesterol, fat and energy metabolism. Using
stable isotope methodologies his group examines the
impact of dietary interventions on metabolism. In
particular his group evaluates plant sterols as functional
foods used to lower cholesterol, and control weight gain.
Dr. Peter Eck investigates the interaction between the
human genome and nutrients and their relationship with
health outcomes. His research program evaluates how
genetic variations in membrane proteins impact
metabolism, and ultimately disease development and
outcome. These investigations may lead to dietary
interventions for diseases such as obesity, type II diabetes,
some cancers, cardiovascular disease and inflammatory
diseases. Dr. Trust Beta investigates age related diseases
and the potential of non-traditional plant components in
the prevention of these diseases.
The Richardson Centre for Functional Foods and
Nutraceuticals has particular strength in functional foods
products from Canadian crops. Isolated components of
Canadian crops have been implicated in the prevention
and/or treatment of many diseases. Recently, Richardson
Centre researcher, Dr. Rotimi Aluko, demonstrated the
blood pressure lowering effect of a pea protein hydrolysate (PPH) using both mouse and human subjects(5). In
vitro the PPH demonstrated activity against renin and
angiotension converting enzyme, enzymes implicated in
hypertension. In a 3-week intervention trial, the authors
reported a significant reduction in systolic blood pressures, suggesting a potential commercial opportunity for
PPH as an anti-hypertension therapy. A second group, led
by Dr, Peter Jones, evaluated the efficacy of a novel
high-oleic rapeseed (canola) oil (HOCO) alone, and
mixed with flaxseed oil, on cardiovascular health(6). In a
trial, hypercholesterolaemic subjects consumed three diets with 70% of fat content provided by either HOCO
alone, a HOCO oil and flaxseed oil blend, or a blend of
oils typical to a western diet. After 28 days, consumption
of the HOCO/flaxseed oil led to a reduction of
LDL-cholesterol by 15.1%, while consumption of HOCO
oil alone led to a reduction of 7.4% when compared to the
western diet. This suggested that consumption of the
HOCO alone or when blended with flaxseed oil is cardioprotective through lipid-lowering effects. Another
study, also conducted by Dr. Jones, using a hypercholes-
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terolaemic, overweight participants found that consumption of a whole and fractionated yellow pea flours at
doses equivalent to half a cup of yellow peas/d reduced
insulin resistance, while whole pea flour reduced android
adiposity in women(7). The use of yellow pea flour as a
functional food ingredient was validated in a related study
that produced banana bread and biscotti with yellow pea
flour. These low-glycemic functional products had sensory attributes that were comparable to identical food
products containing whole wheat flour(8).

THE INSTITUTE OF NUTRACEUTICALS AND
FUNCTIONAL FOODS
The Institute of Nutraceuticals and Functional Foods
(INAF), is situated at the Université Laval in Quebec City,
Quebec. INAF was created in 1999 and is now comprised
of 38 regular, 29 associate and 2 honorary members.
The Institute conducts multi-disciplinary research with
the aim of identifying and isolating bioactive compounds
and the development of functional ingredients and foods
for the benefit of human health. INAF research focuses
on sectors significant to the Quebec economy.
INAF boasts six Canada Research Chairs including:
Research Chair in Lactic Culture Biotechnology for Dairy
and Probiotic Industries (Denis Roy); Research Chair in
Nutrition, Functional Foods and Cardiovascular Health
(Benoît Lamarche); Research Chair in Physical Activity,
Nutrition and Energy Balance (Angelo Tremblay);
Research Chair in Protein, Biosystem and Functional
Food Physical Chemistry (Muriel Subirade); Research
Chair on Use of Dietary Fatty Acids and Cognitive
Functions During Aging Process (Stephen Cunnane) and;
Research Chair in Animal Reproductive Applied
Functional Genomics (Marc-André Sirard). This group
of high caliber researchers is investigating numerous
areas including natural health product delivery systems,
the use of functional foods for the prevention and
treatment of obesity-related diseases and cognitive
disorders and probiotics.
A particular strength of INAF is its contribution to
the investigation of the health benefits of marine derived
products. Ouellet et al.(9) recently demonstrated that cod
protein (CP) improved insulin sensitivity in insulin-resistant subjects. Low-grade inflammation has been
implicated in the development of insulin resistance and
type II diabetes with studies demonstrating that high levels of C-reactive protein and interleukin (IL)-6 are associated with the development of the disease. Consumption of a diet containing CP decreased high-sensitivity
C-reactive protein, suggesting a possible functionally of
CP in the prevention of type II diabetes. This result was
confirmed by a second study that demonstrated expression of both tumor necrosis factor-α and interleukin-6 in
rats was reduced in visceral adipose tissue when fed fish
protein from bonito, herring, mackerel, or salmon compared to the control group(10). Another study, led by Dr.
Fédéric Calon(11) demonstrated that in a mouse model,
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consumption of DHA extracted from fish oil, has a direct
effect on neuronal function. Using an Alzheimer disease
mouse model, 3xTg-AD, the researchers demonstrated an
improved object recognition (↑12%), and partial prevention of seizure-like akinetic episodes (↓50%). This study
demonstrated that DHA can play a possible protective
role against epilepsy and the deterioration of cognitive
performance in Alzheimer patients.

THE CANADIAN CENTRE FOR AGRI-FOOD
RESEARCH IN HEALTH AND MEDICINE
(CCARM)
The Canadian Centre for Agri-food Research in
Health and Medicine (CCARM) is located in Winnipeg
Manitoba and is a partnership between St. Boniface Hospital, the University of Manitoba, and Agriculture and
Agri-Food Canada. It is dedicated to conducting research to add value to traditional agriculture commodities
and produce functional foods and natural health products.
The Centre has particular strength in conducting human
clinical trials on products that have been shown in the lab
to have potential beneficial effects on diseases affecting
millions of Canadians. Currently, CCARM focuses on
immune disorders, diabetes, obesity, and cardiovascular
and vascular diseases.
In one studying undertaken at CCARM the potential
of conjugated linoleic acid (CLA), found in meat and
dairy, as a natural health product for the treatment of cardiac hypertrophy, a major factor in heart failure, was
evaluated. In hypertensive heart failure rats, CLA supplementation was shown to significantly reduce blood
pressure and cardiac hypertrophy(12). The authors noted
these findings were particularly significant given that
~44% of heart failure patients resort to nutrition-based
therapies. A second study, led by Dr. Grant Pierce,
demonstrated that dietary flaxseed may have the potential
to protect against atheroscerlosis development caused by
consumption of industrially hydrogenated trans fatty acids (TFA)(13). Using low-density lipoprotein receptor deficient (LDLr-/-) mice, the team demonstrated that addition of flaxseed to a diet high in TFA and cholesterol significantly reduced atherosclerosis as compared to groups
that did not receive the addition of flaxseed. This work
is significant because despite recommendations to reduce
dietary TFAs, it is impossible to completely avoid their
ingestion.

NUTRIGENOMICS IN CANADA
Canada
has
world-renown
expertise
in
nutrigenomics with a two Canadian Research Chairs, Dr.
Ahmed El-Sohemy, and Dr. Peter Eck. Dr. Ahmed
El-Sohemy at the University of Toronto, leads a research
program that identifies biomarkers of dietary exposure
and elucidates the genetic basis for variability in nutrient
response and dietary preferences. His research group
has established the Toronto Nutrigenomics and Health
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Study, a cross-sectional analysis of diet, genotype and
biomarkers of chronic disease in an ethnoculturally
diverse population of ~2000 young adults. Using the
Study, his research group has demonstrated that genetic
variation in the main target of caffeine action in the
central nervous system affected habitual caffeine
consumption, demonstrating the genetic reason behind an
individual’s desire to consume coffee(14). In another study,
it was demonstrated that genetic variation of GLUT2, a
transmembrane glucose carrier protein, influences sugar
consumption for some individuals(15). The group has also
demonstrated the impact of dietary fatty acids on
cardiometabolic diseases is influenced by small
nucleotide polymorphisms in genes associated with the
body’s inflammatory response(16). Alternatively, Dr. Peter
Eck investigates genetic variations in membrane
transporters. These proteins are involved in absorption,
distribution, and elimination of a large number of dietary
components, and are implicated in disease susceptibility.
Dr. Eck and his team of researchers are characterizing
variations of membrane transporters transporting Vitamin
C(17,18) and glucose(19). Investigations undertaken by
researchers such as Drs. El-Sohemy and Eck, elucidate
the relationship between genes and diet, enabling the
design of tailoured and novel functional foods and natural
health products for the benefit of the health and
well-being of the consumer.

THE ADVANCED FOODS AND MATERIALS
NETWORK
AFMNet was launched in 2003 as a federally funded
Network of Centre of Excellence. Now a not-for-profit,
AFMNet has positioned itself as a leader in food and
health research and innovation, with an international
network of researchers, industry professionals and
government agencies. Its multidisciplinary approach has
brought together researchers and partners who have not
traditionally collaborated in the past. Over the past 7
years, AFMNet funded researchers have investigated
topcis such as: nutrigenomic studies on the effectiveness
of stabilizing reduced folates using nano-encapsulation
technologies (Dr. David Kitts); engineering the oil
binding capacity and rheological properties of
nanocrystalline fat networks with the aim to reduce
partially hydrogenated fats for the Canadian diet (Dr.
Alejandro Marangoni); the impact of apolipoprotein E
polymorphisms on the risk of cognitive decline (Dr.
Stephen Cunnane) and; the impact of diet and gut health
and general well-being (Drs. Martin Kalmokoff and Brent
Selinger). The investments made in AFMNet’s research
program are yielding new strategies to improve the health
and well-being of Canadians.

CONCLUSIONS
It is widely recognized that preventable food-related
chronic disease such as hypertension, cardiovascular
disease, and type II diabetes impose an enormous social
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and economic burden on Canadian society. Efforts to
reduce the incidence of many of these chronic diseases
have been of questionable effectiveness. In part, this
reflects the complexity of relationships between food and
health status. The research and development of functional
foods and natural health products, in conjunction with
elucidation of the impact of genetics on diet-health
relationships has enormous potential of preventing and
treating chronic diseases. Canada’s investment, through
various funding programs including the Canada Research
Chair program and various centres, in functional foods,
natural health products and nutrigenomics research is
leading the innovative approaches to improve the health
and well-being of all Canadians
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